19 June 2013
Keywords: combination, therapy, hcv, zadaxin, sciclone, pharmaceuticals, thymosin
Article | 14 October 1996
SciClone Pharmaceuticals' Zadaxin (thymosin alpha 1) in combination with interferon alpha is more efficacious than IFN alpha alone in treating patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.